[go: up one dir, main page]

DE3481842D1 - Fibronektinkomplexe. - Google Patents

Fibronektinkomplexe.

Info

Publication number
DE3481842D1
DE3481842D1 DE8484100587T DE3481842T DE3481842D1 DE 3481842 D1 DE3481842 D1 DE 3481842D1 DE 8484100587 T DE8484100587 T DE 8484100587T DE 3481842 T DE3481842 T DE 3481842T DE 3481842 D1 DE3481842 D1 DE 3481842D1
Authority
DE
Germany
Prior art keywords
fibroneect
complexes
fibroneect complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484100587T
Other languages
English (en)
Inventor
Yoshio Kagitani
Kenji Tanaka
Yasuo Ueda
Yusei Shiraga
Tunetaka Nakajima
Takuji Doi
Takao Ohmura
Satoshi Funakoshi
Tadakazu Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of DE3481842D1 publication Critical patent/DE3481842D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6435—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8484100587T 1983-01-21 1984-01-20 Fibronektinkomplexe. Expired - Lifetime DE3481842D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58008912A JPS59134732A (ja) 1983-01-21 1983-01-21 フイブロネクチン・生理活性物質複合体の製造法

Publications (1)

Publication Number Publication Date
DE3481842D1 true DE3481842D1 (de) 1990-05-10

Family

ID=11705868

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484100587T Expired - Lifetime DE3481842D1 (de) 1983-01-21 1984-01-20 Fibronektinkomplexe.

Country Status (5)

Country Link
US (1) US4560556A (de)
EP (1) EP0114685B1 (de)
JP (1) JPS59134732A (de)
CA (1) CA1223202A (de)
DE (1) DE3481842D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60226819A (ja) * 1984-04-25 1985-11-12 Green Cross Corp:The フイブロネクチン複合体
AT385658B (de) * 1985-03-28 1988-05-10 Serotherapeutisches Inst Wien Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4587122A (en) * 1985-04-23 1986-05-06 The Green Cross Corporation Fibronectin-dextran-drug complex and method of preparation thereof
GB8516421D0 (en) * 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US5011686A (en) * 1987-09-21 1991-04-30 Creative Biomolecules, Inc. Thrombus specific conjugates
GB8722470D0 (en) * 1987-09-24 1987-10-28 Blackmore D J Production of anti-genic protein-hapten conjugates
CA2021942C (en) * 1989-08-10 2001-04-10 Michel Page Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent
WO1995033492A1 (en) * 1994-06-09 1995-12-14 Houston Biotechnology Incorporated Methods and compositions for modulation of wound healing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5141603B2 (de) * 1974-06-08 1976-11-11
DE2460753A1 (de) * 1974-12-21 1976-06-24 Hoechst Ag Verfahren zur herstellung von humaninsulin
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4315906A (en) * 1979-05-21 1982-02-16 New England Nuclear Corporation Cold insoluble globulin, its purification and use
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
FR2470794A1 (fr) * 1979-12-05 1981-06-12 Pasteur Institut Nouvelles microparticules, leur preparation et leurs applications en biologie, notamment a la culture de cellules diploides humaines
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4341764A (en) * 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor
JPS56125317A (en) * 1980-03-08 1981-10-01 Nippon Mejifuijitsukusu Kk Stable radioactive diagnosticum with radioactive metallic mark
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
US4391749A (en) * 1981-10-19 1983-07-05 La Jolla Cancer Research Foundation Method for the purification of collagens

Also Published As

Publication number Publication date
EP0114685B1 (de) 1990-04-04
EP0114685A2 (de) 1984-08-01
EP0114685A3 (en) 1987-02-04
CA1223202A (en) 1987-06-23
JPS59134732A (ja) 1984-08-02
US4560556A (en) 1985-12-24

Similar Documents

Publication Publication Date Title
DE3484505D1 (de) Immuntest.
DE3486259D1 (de) Carboxyalkenamidocephalosporine.
FI73494B (fi) Stoedsko.
FI830256L (fi) Silplaot.
DE3481389D1 (de) Mikrorechner.
FI844297L (fi) Behandlingsstation foer en elektrografisk informationsskrivare.
DE3484698D1 (de) Antitumormittel.
FI841180A (fi) Inriktningssystem foer fordon.
DE3482323D1 (de) Benzopyranisomere.
DE3480652D1 (de) Benzocycloalkanderivate.
DE3485948D1 (de) Hepatitis-a-untereinheit-antigen.
FI73488B (fi) Syllkonstruktion.
DE3481842D1 (de) Fibronektinkomplexe.
NO152835C (no) Fremfoeringsanordning.
DE3484095D1 (de) Transformatorlose gegentaktendstufe.
FI834652A (fi) Laminerad spegel.
DE3483137D1 (de) Ec-torfeld.
FI830202L (fi) Hugg.
FI851235A0 (fi) Kabelstraeckningsanordning.
FI842234A0 (fi) Vinkelfoerbindning.
DE3485726D1 (de) Mikropozessor.
FI842743A (fi) Foerfarande foer framstaellning av -l-aspartyl-l-fenylalaninalkylester.
FI861754A0 (fi) Ankaranordning.
FI830108L (fi) Dubbningsmaskin.
ATE77148T1 (de) Antikoerper-metallionen-komplexe.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: THE GREEN CROSS CORP., OSAKA, JP

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee